Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Radiotherapy Dosage"" wg kryterium: Temat


Tytuł:
Five-year clinical outcomes of scanning carbon-ion radiotherapy for prostate cancer.
Autorzy:
Takakusagi Y; Department of Radiation Oncology, Kanagawa Cancer Center, Kanagawa, Japan.; Department of Radiation Oncology, Yokohama Sakae Kyosai Hospital, Yokohama, Japan.
Koge H; Department of Radiation Oncology, Kanagawa Cancer Center, Kanagawa, Japan.
Kano K; Department of Radiation Oncology, Kanagawa Cancer Center, Kanagawa, Japan.
Shima S; Department of Radiation Oncology, Kanagawa Cancer Center, Kanagawa, Japan.
Tsuchida K; Department of Radiation Oncology, Kanagawa Cancer Center, Kanagawa, Japan.
Mizoguchi N; Department of Radiation Oncology, Kanagawa Cancer Center, Kanagawa, Japan.
Yoshida D; Department of Radiation Oncology, Kanagawa Cancer Center, Kanagawa, Japan.
Kamada T; Department of Radiation Oncology, Kanagawa Cancer Center, Kanagawa, Japan.
Katoh H; Department of Radiation Oncology, Kanagawa Cancer Center, Kanagawa, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 08; Vol. 19 (3), pp. e0290617. Date of Electronic Publication: 2024 Mar 08 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*
Radiotherapy, Intensity-Modulated*/methods
Male ; Humans ; Middle Aged ; Aged ; Aged, 80 and over ; Retrospective Studies ; Neoplasm Recurrence, Local ; Treatment Outcome ; Carbon ; Radiotherapy Dosage
Czasopismo naukowe
Tytuł:
Use of focal radiotherapy boost for prostate cancer: radiation oncologists' perspectives and perceived barriers to implementation.
Autorzy:
Zhong AY; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA.
Lui AJ; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA.
Katz MS; Department of Radiation Medicine, Lowell General Hospital, Lowell, MA, USA.
Berlin A; Radiation Medicine Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
Kamran SC; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Kishan AU; Departments of Radiation Oncology and Urology, UCLA, Los Angeles, CA, USA.
Murthy V; ACTREC, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Nagar H; Weill Cornell Medicine, New York, NY, USA.
Seible D; Anchorage and Valley Radiation Therapy Centers, Anchorage, AK, USA.
Stish BJ; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Tree AC; The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, London, UK.
Seibert TM; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA. .; Departments of Radiology and Bioengineering, University of California San Diego, La Jolla, CA, USA. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2023 Nov 11; Vol. 18 (1), pp. 188. Date of Electronic Publication: 2023 Nov 11.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/pathology
Radiation Oncologists*
Humans ; Male ; Magnetic Resonance Imaging ; Prostate/pathology ; Radiotherapy Dosage ; United States
Czasopismo naukowe
Tytuł:
Clinical Efficacy and Openness to New Challenges of Low Dose Rate Brachytherapy for Prostate Cancer.
Autorzy:
Kato M; Aichi Cancer Center, Urology, Nagoya 464-8681, Japan.
Higashi S; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Tsu 514-0001, Japan.
Sugino Y; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Tsu 514-0001, Japan.
Kajiwara S; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Tsu 514-0001, Japan.
Tanaka S; Aichi Cancer Center, Urology, Nagoya 464-8681, Japan.
Kitano G; Aichi Cancer Center, Urology, Nagoya 464-8681, Japan.
Yamashita Y; Matsusaka Chuo General Hospital, Radiology, Matsusaka 515-0818, Japan.
Ogura Y; Kuwana City Medical Center, Urology, Kuwana 511-0061, Japan.
Tachibana H; Aichi Cancer Center, Urology, Nagoya 464-8681, Japan.
Kojima T; Aichi Cancer Center, Urology, Nagoya 464-8681, Japan.
Inoue T; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Tsu 514-0001, Japan.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Nov 08; Vol. 30 (11), pp. 9824-9835. Date of Electronic Publication: 2023 Nov 08.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Prostatic Neoplasms*/therapy
Brachytherapy*
Male ; Humans ; Androgen Antagonists/therapeutic use ; Radiotherapy Dosage ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Plan robustness evaluation strategies in whole-pelvic proton therapy for high-risk prostate cancer patients within a randomised clinical trial.
Autorzy:
Tilbæk S; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Petersen SE; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
Stolarczyk L; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
Vestergaard A; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
Rønde HS; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
Bentzen LN; Department of Oncology, Vejle Hospital, University of Southern Denmark, Vejle, Denmark.
Søndergaard J; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark.
Høyer M; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Muren LP; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Nov; Vol. 62 (11), pp. 1455-1460. Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Proton Therapy*/methods
Radiotherapy, Intensity-Modulated*/methods
Prostatic Neoplasms*
Male ; Humans ; Radiotherapy Planning, Computer-Assisted/methods ; Organs at Risk ; Radiotherapy Dosage
Czasopismo naukowe
Tytuł:
A systematic planning method to spare the rectal wall in radiotherapy of prostate cancer.
Autorzy:
Jakobsen K; Department of Clinical Oncology, Zealand University Hospital, Køge, Denmark.
Kaplan LP; Department of Clinical Oncology, Zealand University Hospital, Køge, Denmark.
Marsguerra R; Department of Oncology, Rigshospitalet, Denmark.
Bebek M; Department of Clinical Oncology, Zealand University Hospital, Køge, Denmark.
Hoffland KF; Department of Clinical Oncology, Zealand University Hospital, Køge, Denmark.
Hinsby ES; Department of Clinical Oncology, Zealand University Hospital, Køge, Denmark.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Nov; Vol. 62 (11), pp. 1451-1454. Date of Electronic Publication: 2023 Sep 15.
Typ publikacji:
Letter
MeSH Terms:
Prostatic Neoplasms*/radiotherapy
Radiotherapy, Conformal*
Male ; Humans ; Rectum ; Radiotherapy Planning, Computer-Assisted ; Radiotherapy Dosage
Opinia redakcyjna
Tytuł:
Increasing rectum-prostate distance using a hydrogel spacer to reduce radiation exposure during proton beam therapy for prostate cancer.
Autorzy:
Narukawa T; Department of Urology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan. .
Aibe N; Department of Radiology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan.
Tsujimoto M; Department of Urology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan.
Shiraishi T; Department of Urology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan.
Kimoto T; Department of Radiology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan.
Suzuki G; Department of Radiology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan.
Ueda T; Department of Urology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan.
Fujihara A; Department of Urology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan.
Yamazaki H; Department of Radiology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan.
Ukimura O; Department of Urology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Oct 26; Vol. 13 (1), pp. 18319. Date of Electronic Publication: 2023 Oct 26.
Typ publikacji:
Journal Article
MeSH Terms:
Proton Therapy*
Radiation Injuries*
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/chemically induced
Radiation Exposure*
Male ; Humans ; Prostate ; Rectum ; Hydrogels ; Hydrogel, Polyethylene Glycol Dimethacrylate ; Radiotherapy Dosage
Czasopismo naukowe
Tytuł:
Reduction of PTV margins for elective pelvic lymph nodes in online adaptive radiotherapy of prostate cancer patients.
Autorzy:
Brennsæter JA; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.
Dahle TJ; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.
Moi JN; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.
Svanberg IF; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.
Haaland GS; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.
Pilskog S; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.; Department of Physics and Technology, University of Bergen, Bergen, Norway.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Oct; Vol. 62 (10), pp. 1208-1214. Date of Electronic Publication: 2023 Sep 08.
Typ publikacji:
Journal Article
MeSH Terms:
Radiotherapy, Image-Guided*/methods
Prostatic Neoplasms*/radiotherapy
Radiotherapy, Intensity-Modulated*/methods
Male ; Humans ; Radiotherapy Planning, Computer-Assisted/methods ; Prostate/pathology ; Lymph Nodes/pathology ; Cone-Beam Computed Tomography/methods ; Radiotherapy Dosage
Czasopismo naukowe
Tytuł:
The Current Trend of Radiation Therapy for Patients with Localized Prostate Cancer.
Autorzy:
Numakura K; Department of Urology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
Kobayashi M; Department of Urology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
Muto Y; Department of Urology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
Sato H; Department of Urology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
Sekine Y; Department of Urology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
Sobu R; Department of Urology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
Aoyama Y; Department of Urology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
Takahashi Y; Department of Urology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
Okada S; Department of Urology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
Sasagawa H; Department of Urology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
Narita S; Department of Urology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
Kumagai S; Department of Radiology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
Wada Y; Department of Radiology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
Mori N; Department of Radiology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
Habuchi T; Department of Urology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Sep 01; Vol. 30 (9), pp. 8092-8110. Date of Electronic Publication: 2023 Sep 01.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Radiotherapy, Intensity-Modulated*/methods
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/etiology
Male ; Humans ; Radiotherapy Dosage ; Prostate/radiation effects ; Rectum/radiation effects
Czasopismo naukowe
Tytuł:
Dosimetric comparison between intensity-modulated radiation therapy and volumetric-modulated arc therapy to enhance bladder and bowel.
Autorzy:
Saddik MZ; Department of Pharmacology/ Medical Physics/ and Clinical Biochemistry, College of Medicine, Hawler Medical University, Erbil, Iraq.
Hassan FF; Department of Pharmacology/ Medical Physics/ and Clinical Biochemistry, College of Medicine, Hawler Medical University, Erbil, Iraq.
Pokaż więcej
Źródło:
Journal of medicine and life [J Med Life] 2023 Sep; Vol. 16 (9), pp. 1381-1387.
Typ publikacji:
Journal Article
MeSH Terms:
Radiotherapy, Intensity-Modulated*/methods
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/radiotherapy
Male ; Humans ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted/methods ; Urinary Bladder/diagnostic imaging ; Organs at Risk
Czasopismo naukowe
Tytuł:
Experimental validation of a novel method of dose accumulation for the rectum.
Autorzy:
Patrick HM; Medical Physics Unit, McGill University, Montreal, Québec, Canada.
Poon E; Department of Medical Physics, McGill University Health Centre, Montreal, Québec, Canada.
Kildea J; Medical Physics Unit, McGill University, Montreal, Québec, Canada.; Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, Québec, Canada.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Aug; Vol. 62 (8), pp. 915-922. Date of Electronic Publication: 2023 Jul 28.
Typ publikacji:
Journal Article
MeSH Terms:
Rectum*/diagnostic imaging
Prostatic Neoplasms*
Male ; Humans ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted/methods ; Pelvis ; Phantoms, Imaging
Czasopismo naukowe
Tytuł:
In silico comparison of whole pelvis intensity-modulated photon versus proton therapy for the postoperative management of prostate cancer.
Autorzy:
Gogineni E; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Cruickshank IK; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Chen H; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Halthore A; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Li H; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Deville C; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Jun; Vol. 62 (6), pp. 642-647. Date of Electronic Publication: 2023 Jun 22.
Typ publikacji:
Journal Article
MeSH Terms:
Proton Therapy*
Radiotherapy, Intensity-Modulated*
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/pathology
Male ; Humans ; Protons ; Radiotherapy Planning, Computer-Assisted ; Pelvis/pathology ; Radiotherapy Dosage ; Organs at Risk/radiation effects
Czasopismo naukowe
Tytuł:
Optimizing 3DCT image registration for interfractional changes in carbon-ion prostate radiotherapy.
Autorzy:
Hirai R; National Institutes for Quantum Science and Technology, Quantum Life and Medical Science Directorate, Institute for Quantum Medical Science, Inage-ku, Chiba, 263-8555, Japan.; Corporate Research and Development Center, Toshiba Corporation, Kanagawa, 212-8582, Japan.; Department of Information and Image Sciences, Faculty of Engineering, Chiba University, Inage-ku, Chiba, 263-8522, Japan.
Mori S; National Institutes for Quantum Science and Technology, Quantum Life and Medical Science Directorate, Institute for Quantum Medical Science, Inage-ku, Chiba, 263-8555, Japan. .
Suyari H; Department of Information and Image Sciences, Faculty of Engineering, Chiba University, Inage-ku, Chiba, 263-8522, Japan.
Tsuji H; QST Hospital, National Institutes for Quantum Science and Technology, Inage-ku, Chiba, 263-8555, Japan.
Ishikawa H; QST Hospital, National Institutes for Quantum Science and Technology, Inage-ku, Chiba, 263-8555, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 May 08; Vol. 13 (1), pp. 7448. Date of Electronic Publication: 2023 May 08.
Typ publikacji:
Journal Article
MeSH Terms:
Heavy Ion Radiotherapy*
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/drug therapy
Radiotherapy, Intensity-Modulated*/methods
Male ; Humans ; Prostate ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted/methods ; Carbon/therapeutic use ; Organs at Risk
Czasopismo naukowe
Tytuł:
Radiobiological modeling of radiation-induced acute proctitis: A single-institutional study of prostate carcinoma.
Autorzy:
Singh B; Centre for Medical Physics, Panjab University, Chandigarh; Department of Radiation Oncology, Max Superspeciality Hospital, Bathinda, Punjab, India.
Singh G; Centre for Medical Physics, Panjab University; Department of Radiotherapy, PGIMER, Chandigarh, Punjab, India.
Oinam AS; Department of Radiotherapy, PGIMER, Chandigarh, Punjab, India.
Singh M; Department of Radiation Oncology, Max Superspeciality Hospital, Bathinda, Punjab, India.
Kumar V; Centre for Medical Physics, Panjab University, Chandigarh, Punjab, India.
Vashistha R; Department of Radiation Oncology, Max Superspeciality Hospital, Bathinda, Punjab, India.
Sidhu MS; Department of Radiation Oncology, Max Superspeciality Hospital, Bathinda, Punjab, India.
Katake A; Department of Radiation Oncology, Max Superspeciality Hospital, Bathinda, Punjab, India.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Apr-Jun; Vol. 19 (3), pp. 664-670.
Typ publikacji:
Journal Article
MeSH Terms:
Proctitis*/etiology
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/complications
Radiation Injuries*/etiology
Radiotherapy, Intensity-Modulated*/adverse effects
Carcinoma*/complications
Male ; Humans ; Prostate ; Rectum ; Radiotherapy Dosage
Czasopismo naukowe
Tytuł:
Dosimetric analysis of patients receiving radiotherapy with VMAT technique in localized prostate cancer and its correlation with side effects.
Autorzy:
Akay SU; Marmara University Radiation Oncology Department, Marmara University, İstanbul, Turkey.
Çetin İA; Marmara University Radiation Oncology Department, Marmara University, İstanbul, Turkey.
Bekiroğlu GN; Marmara University Biostatistics Department, Marmara University, İstanbul, Turkey.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Apr-Jun; Vol. 19 (3), pp. 801-807.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/radiotherapy
Drug-Related Side Effects and Adverse Reactions*
Radiotherapy, Intensity-Modulated*/adverse effects
Radiotherapy, Intensity-Modulated*/methods
Male ; Humans ; Radiotherapy Dosage ; Rectum ; Radiotherapy Planning, Computer-Assisted/methods ; Testosterone
Czasopismo naukowe
Tytuł:
Comprehensive review of the use of hydrogel spacers prior to radiation therapy for prostate cancer.
Autorzy:
Harvey M; Urology Department, Austin Health, Melbourne, Vic., Australia.
Ong WL; Department of Radiation Oncology, Alfred Health, Melbourne, Vic., Australia.; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., Australia.
Chao M; Department of Radiation Oncology, Olivia Newton John Cancer Wellness and Research Centre, Austin Health, Melbourne, Vic., Australia.; Genesis Cancer Care Victoria, Ringwood East, Vic., Australia.
Udovicich C; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Vic., Australia.
McBride S; Radiation Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Bolton D; Urology Department, Austin Health, Melbourne, Vic., Australia.
Eastham J; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Perera M; Urology Department, Austin Health, Melbourne, Vic., Australia.; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2023 Mar; Vol. 131 (3), pp. 280-287. Date of Electronic Publication: 2022 Jun 24.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Hydrogels*
Prostatic Neoplasms*/surgery
Humans ; Male ; Prostate ; Radiometry ; Radiotherapy Dosage ; Rectum
Czasopismo naukowe
Tytuł:
Circulating microvesicles correlate with radiation proctitis complication after radiotherapy.
Autorzy:
Ribault A; Institut de Radioprotection Et de Sûreté Nucléaire (IRSN), PSE-SANTE, BP17, 92262, Fontenay-aux-Roses Cedex, France.
Benadjaoud MA; Institut de Radioprotection Et de Sûreté Nucléaire (IRSN), PSE-SANTE, BP17, 92262, Fontenay-aux-Roses Cedex, France. .
Squiban C; Institut de Radioprotection Et de Sûreté Nucléaire (IRSN), PSE-SANTE, BP17, 92262, Fontenay-aux-Roses Cedex, France.
Arnaud L; Department of Hematology, Biogenopole, CHU La Timone, APHM, Marseille, France.
Judicone C; Department of Hematology, Biogenopole, CHU La Timone, APHM, Marseille, France.
Leroyer AS; Aix-Marseille University, C2VN, INSERM 1263, INRAE 1260, Marseille, France.
Rousseau A; Hôpital Saint Antoine, APHP, Unité de Recherche Clinique de L'Est Parisien (URC-Est), Paris, France.
Huet C; Institut de Radioprotection Et de Sûreté Nucléaire (IRSN), PSE-SANTE, BP17, 92262, Fontenay-aux-Roses Cedex, France.
Guha C; Department of Radiation Oncology, Albert Einstein College of Medicine, New York, USA.
Benderitter M; Institut de Radioprotection Et de Sûreté Nucléaire (IRSN), PSE-SANTE, BP17, 92262, Fontenay-aux-Roses Cedex, France.
Lacroix R; Department of Hematology, Biogenopole, CHU La Timone, APHM, Marseille, France.; Aix-Marseille University, C2VN, INSERM 1263, INRAE 1260, Marseille, France.
Flamant S; Institut de Radioprotection Et de Sûreté Nucléaire (IRSN), PSE-SANTE, BP17, 92262, Fontenay-aux-Roses Cedex, France.
Chen EI; Department of Pharmacology, Columbia University Medical Center, New York, USA.
Simon JM; Hôpital Pitié-Salpêtrière, Sorbonne Université́, Service d'Oncologie Radiothérapie, Assistance Publique-Hôpitaux de Paris (APHP), 75013, Paris, France.
Tamarat R; Institut de Radioprotection Et de Sûreté Nucléaire (IRSN), PSE-SANTE, BP17, 92262, Fontenay-aux-Roses Cedex, France. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Feb 04; Vol. 13 (1), pp. 2033. Date of Electronic Publication: 2023 Feb 04.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Gastritis*
Proctitis*/etiology
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/radiotherapy
Radiation Injuries*/pathology
Rectum*/pathology
Rectum*/radiation effects
Humans ; Male ; Radiotherapy Dosage ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Hyaluronic acid spacer in prostate cancer radiotherapy: dosimetric effects, spacer stability and long-term toxicity and PRO in a phase II study.
Autorzy:
Björeland U; Department of Radiation Sciences, Radiation Physics, Umeå University, 901 87, Umeå, Sweden. .
Notstam K; Department of Radiation Sciences, Oncology, Umeå University, 901 87, Umeå, Sweden.
Fransson P; Department of Nursing, Umeå University, 901 87, Umeå, Sweden.
Söderkvist K; Department of Radiation Sciences, Oncology, Umeå University, 901 87, Umeå, Sweden.
Beckman L; Department of Radiation Sciences, Oncology, Umeå University, 901 87, Umeå, Sweden.
Jonsson J; Department of Radiation Sciences, Radiation Physics, Umeå University, 901 87, Umeå, Sweden.
Nyholm T; Department of Radiation Sciences, Radiation Physics, Umeå University, 901 87, Umeå, Sweden.
Widmark A; Department of Radiation Sciences, Oncology, Umeå University, 901 87, Umeå, Sweden.
Thellenberg Karlsson C; Department of Radiation Sciences, Oncology, Umeå University, 901 87, Umeå, Sweden.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2023 Jan 02; Vol. 18 (1), pp. 1. Date of Electronic Publication: 2023 Jan 02.
Typ publikacji:
Clinical Trial, Phase II; Journal Article
MeSH Terms:
Hyaluronic Acid*/therapeutic use
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/radiotherapy
Humans ; Male ; Patient Reported Outcome Measures ; Radiotherapy Dosage ; Rectum ; Radiotherapy/adverse effects
Czasopismo naukowe
Tytuł:
A dose escalated fiducial marker-based image guided radical radiotherapy in locally advanced prostate cancers: A single institute experience from India.
Autorzy:
Gupta PK; Department of Radiation Oncology, Kalyan Singh Super Speciality Cancer Institute; Department of Radiotherapy, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Rastogi N; Department of Radiotherapy, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Maria Das KJ; Department of Radiotherapy, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Kumar S; Department of Radiotherapy, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Jan-Mar; Vol. 19 (2), pp. 382-388.
Typ publikacji:
Journal Article
MeSH Terms:
Radiotherapy, Image-Guided*/methods
Prostatic Neoplasms*/pathology
Radiotherapy, Intensity-Modulated*/adverse effects
Radiotherapy, Intensity-Modulated*/methods
Male ; Humans ; Aged ; Fiducial Markers ; Prostate-Specific Antigen ; Retrospective Studies ; Neoplasm Recurrence, Local/radiotherapy ; Neoplasm Recurrence, Local/etiology ; Radiotherapy Dosage
Czasopismo naukowe
Tytuł:
Role of hydrogel spacer to protect the rectum from thermal injury in focal therapy of prostate cancer: Preclinical study in cadaver model.
Autorzy:
Narukawa T; Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Fujihara A; Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Ochiai A; Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Okihara K; Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Hongo F; Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Ukimura O; Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Pokaż więcej
Źródło:
International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2023 Jan; Vol. 30 (1), pp. 116-118. Date of Electronic Publication: 2022 Dec 09.
Typ publikacji:
Journal Article
MeSH Terms:
Hydrogels*/therapeutic use
Prostatic Neoplasms*
Male ; Humans ; Rectum/surgery ; Pelvis ; Cadaver ; Radiotherapy Dosage ; Hydrogel, Polyethylene Glycol Dimethacrylate
Czasopismo naukowe
Tytuł:
Conventional dose versus dose escalated radiotherapy including high-dose-rate brachytherapy boost for patients with Gleason score 9-10 clinical localized prostate cancer.
Autorzy:
Yamazaki H; Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajiicho Kawaramachi Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. .
Suzuki G; Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajiicho Kawaramachi Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.
Aibe N; Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajiicho Kawaramachi Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.
Shimizu D; Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajiicho Kawaramachi Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.
Kimoto T; Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajiicho Kawaramachi Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.
Masui K; Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajiicho Kawaramachi Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.
Yoshida K; Department of Radiology, Kansai Medical University, Hirakata, 573-1010, Japan.
Nakamura S; Department of Radiology, Kansai Medical University, Hirakata, 573-1010, Japan.
Okabe H; Department of Radiology, Ujitakeda Hospital, Uji-City, Kyoto, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jan 07; Vol. 12 (1), pp. 268. Date of Electronic Publication: 2022 Jan 07.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study
MeSH Terms:
Brachytherapy*/adverse effects
Brachytherapy*/mortality
Radiotherapy Dosage*
Radiotherapy, Intensity-Modulated*/adverse effects
Radiotherapy, Intensity-Modulated*/mortality
Prostatic Neoplasms/*radiotherapy
Aged ; Aged, 80 and over ; Disease-Free Survival ; Humans ; Japan ; Male ; Middle Aged ; Neoplasm Grading ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Retrospective Studies ; Time Factors
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies